Compounds and Clinical Trial Results
The CuraBase® database contains information on 100s of compounds. These include FDA approved agents as well as compounds currently underging preclinical or clinical evaluation.
Recently Updated: Sorafenib (Nexavar, Onyx Pharmaceuticals), XL147, XL184, XL765, XL880 (Exelixis), Telatinib (ACT Biotech), CAL-101 (Calistoga Pharm.), Pazopanib (GlaxoSmithKline), CPX-1 (Celator),
BSI-201 (BiParsciences), PLX4032 (Plexxicon)
New compounds presented at the 2009 AACR meeting now in the database.
|
Comprehensive Information Related to Individual Cancer Types
Free (no sign up required) access to a catalogue of recurrent molecular aberrations in cancer.
Recently Updated Molecular Aberrations:
PI3 Kinase amplification in non-small cell lung cancer
CuraBase® collects information on clinical trials in all malignant diseases.
Recently Added:
A Phase-I study of XL-184 administered orally to patients wtih advanced malignancies, including a subgroup of patients with medullary thyroid cancer (MTC)
|